Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)

April 24, 2026 6:42 AM
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $55.00 price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments